Skip to main content
Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · IEX Real-Time Price · USD
0.685
-0.005 (-0.80%)
At close: May 1, 2024, 4:00 PM
0.689
+0.004 (0.66%)
After-hours: May 1, 2024, 5:59 PM EDT

Atara Biotherapeutics Revenue

In the year 2023, Atara Biotherapeutics had annual revenue of $8.57M, a decrease of -86.51%. Revenue in the quarter ending December 31, 2023 was $4.25M with 1,823.98% year-over-year growth.

Revenue (ttm)
$8.57M
Revenue Growth
-86.51%
P/S Ratio
9.53
Revenue / Employee
$38,102
Employees
225
Market Cap
81.70M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20238.57M-55.00M-86.51%
Dec 31, 202263.57M43.23M212.55%
Dec 31, 202120.34M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PetMed Express 276.97M
Burning Rock Biotech 75.80M
Protalix BioTherapeutics 65.49M
SHL Telemedicine 57.08M
ProPhase Labs 44.38M
Forian 20.48M
Affimed 9.19M
Envoy Medical 316.00K
Revenue Rankings

ATRA News

More News